Suppr超能文献

品系差异而非高血糖决定了小鼠肾小球硬化的严重程度。

Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice.

作者信息

Zheng F, Striker G E, Esposito C, Lupia E, Striker L J

机构信息

Renal Cell Biology Section, NIDDK, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Kidney Int. 1998 Dec;54(6):1999-2007. doi: 10.1046/j.1523-1755.1998.00219.x.

Abstract

BACKGROUND

We reported that ROP, but not C57, mice were prone to glomerulosclerosis (GS) after nephron reduction (J Clin Invest 97:1242, 1996).

METHODS

In this study, we induced diabetes in ROP and C57 mice to determine if the glomerulosclerotic response was stimulus specific. We used the oligosyndactyly mutation (Os), to produce a congenital 50% reduction in nephron number. Stable hyperglycemia was induced by streptozotocin and mice were maintained for 12 weeks without insulin treatment.

RESULTS

Glomerular hypertrophy occurred in diabetic ROP +/+ and C57 +/+ mice, but glomeruli of diabetic ROP +/+ mice had 1.92-fold higher laminin B1 and 1.5-fold higher tenascin mRNA levels than diabetic C57 +/+ mice. Diabetic ROP Os/+ mice had severe glomerulosclerosis with arteriolar and tubulointerstitial lesions while there was only moderate mesangial sclerosis in diabetic C57 Os/+ mice. Glomerular size was increased in all non-diabetic Os/+ mice. It was further increased in diabetic ROP Os/+ mice, but not in diabetic C57 Os/+ mice. Glomerular mRNA levels were higher in diabetic ROP OS/+ than in diabetic C57 OS/+ mice [alpha 1 (i.v.) collagen 3.2-fold, laminin B1 2.1-fold, and tenascin 1.6-fold].

CONCLUSION

Overall, our data further support the hypothesis that the susceptibility to glomerulosclerosis is inherited, and suggest that hyperglycemia serves principally as a triggering event in the development of diabetic nephropathy. Since the acceleration of diabetic nephropathy by nephron reduction was also largely strain dependent, it appears that the propensity to glomerulosclerosis is a general renal response and is not stimulus specific.

摘要

背景

我们曾报道,肾单位减少后,ROP小鼠而非C57小鼠易发生肾小球硬化(GS)(《临床研究杂志》97:1242, 1996)。

方法

在本研究中,我们在ROP和C57小鼠中诱导糖尿病,以确定肾小球硬化反应是否具有刺激特异性。我们利用少指畸形突变(Os)使肾单位数量先天性减少50%。通过链脲佐菌素诱导稳定的高血糖,且小鼠在无胰岛素治疗的情况下维持12周。

结果

糖尿病ROP +/+和C57 +/+小鼠出现肾小球肥大,但糖尿病ROP +/+小鼠的肾小球层粘连蛋白B1和腱生蛋白mRNA水平分别比糖尿病C57 +/+小鼠高1.92倍和1.5倍。糖尿病ROP Os/+小鼠出现严重的肾小球硬化并伴有小动脉和肾小管间质病变,而糖尿病C57 Os/+小鼠仅出现中度系膜硬化。所有非糖尿病Os/+小鼠的肾小球大小均增加。糖尿病ROP Os/+小鼠的肾小球大小进一步增加,但糖尿病C57 Os/+小鼠未出现这种情况。糖尿病ROP OS/+小鼠的肾小球mRNA水平高于糖尿病C57 OS/+小鼠[α1(IV型)胶原3.2倍、层粘连蛋白B1 2.1倍、腱生蛋白1.6倍]。

结论

总体而言,我们的数据进一步支持肾小球硬化易感性是遗传的这一假说,并表明高血糖主要作为糖尿病肾病发展中的触发事件。由于肾单位减少对糖尿病肾病的加速作用在很大程度上也依赖于品系,因此肾小球硬化倾向似乎是一种普遍的肾脏反应,并非刺激特异性的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验